-
1
-
-
0031001054
-
Potentially avoidable hospitalizations: Inequalities in rates between US socioeconomic groups
-
Pappas G, Hadden WC, Kozak LJ, Fisher GF. Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups. Am J Public Health 1997; 87(5):811-816.
-
(1997)
Am J Public Health
, vol.87
, Issue.5
, pp. 811-816
-
-
Pappas, G.1
Hadden, W.C.2
Kozak, L.J.3
Fisher, G.F.4
-
2
-
-
0025148981
-
Changing patterns of asthma hospitalization among children: 1979 to 1987
-
Gergen PJ, Weiss KB. Changing patterns of asthma hospitalization among children: 1979 to 1987. JAMA 1990; 264(13):1688-1692.
-
(1990)
JAMA
, vol.264
, Issue.13
, pp. 1688-1692
-
-
Gergen, P.J.1
Weiss, K.B.2
-
3
-
-
0023938679
-
Poverty, race, and hospitalization for childhood asthma
-
Wissow LS, Gittelsohn AM, Szklo M, Starfield B, Mussman M. Poverty, race, and hospitalization for childhood asthma. Am J Public Health 1988; 78(7):777-782.
-
(1988)
Am J Public Health
, vol.78
, Issue.7
, pp. 777-782
-
-
Wissow, L.S.1
Gittelsohn, A.M.2
Szklo, M.3
Starfield, B.4
Mussman, M.5
-
4
-
-
0026540917
-
Variations in asthma hospitalizations and deaths in New York City
-
Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health 1992; 82(1):59-65.
-
(1992)
Am J Public Health
, vol.82
, Issue.1
, pp. 59-65
-
-
Carr, W.1
Zeitel, L.2
Weiss, K.3
-
5
-
-
0029028941
-
Use of health services by African-American children with asthma on Medicaid
-
Lozano P, Connell FA, Koepsell TD. Use of health services by African-American children with asthma on Medicaid. JAMA 1995; 274(6):469-473.
-
(1995)
JAMA
, vol.274
, Issue.6
, pp. 469-473
-
-
Lozano, P.1
Connell, F.A.2
Koepsell, T.D.3
-
6
-
-
0031902619
-
Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients
-
Balkrishnan R, Norwood GJ, Anderson A. Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients. Clin Ther 1998; 20(3):567-580.
-
(1998)
Clin Ther
, vol.20
, Issue.3
, pp. 567-580
-
-
Balkrishnan, R.1
Norwood, G.J.2
Anderson, A.3
-
7
-
-
0002981074
-
Outcomes and cost benefit associated with introduction of inhaled corticosteroid therapy in a medicaid enrolled asthmatic children
-
Balkrishnan R, Norwood GJ, Anderson A. Outcomes and cost benefit associated with introduction of inhaled corticosteroid therapy in a medicaid enrolled asthmatic children. Drug Benefit Trends 1998; 10(10):37-40.
-
(1998)
Drug Benefit Trends
, vol.10
, Issue.10
, pp. 37-40
-
-
Balkrishnan, R.1
Norwood, G.J.2
Anderson, A.3
-
8
-
-
0012793107
-
Costs and utilization patterns associated with persistent asthma. A comparison of Texas Medicaid patients with and without continuous inhaled corticosteroid treatment
-
Smith MJ, Rascati KL, Johnsrud MT. Costs and utilization patterns associated with persistent asthma. A comparison of Texas Medicaid patients with and without continuous inhaled corticosteroid treatment. J Manag Care Pharm 2001; 7(6):452-459.
-
(2001)
J Manag Care Pharm
, vol.7
, Issue.6
, pp. 452-459
-
-
Smith, M.J.1
Rascati, K.L.2
Johnsrud, M.T.3
-
9
-
-
0035668228
-
Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: A 1-year follow-up
-
Stempel DA. Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up. Respir Med 2001; 95:992-998.
-
(2001)
Respir Med
, vol.95
, pp. 992-998
-
-
Stempel, D.A.1
-
10
-
-
0035144820
-
One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma
-
Stempel DA, Meyer JW, Stanford RH, Yancey SW. One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma. J Allergy Clin Immunol 2001; 107:94-98.
-
(2001)
J Allergy Clin Immunol
, vol.107
, pp. 94-98
-
-
Stempel, D.A.1
Meyer, J.W.2
Stanford, R.H.3
Yancey, S.W.4
-
11
-
-
0034944210
-
Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast
-
Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Respir Med 2001; 95:227-234.
-
(2001)
Respir Med
, vol.95
, pp. 227-234
-
-
Stempel, D.A.1
Mauskopf, J.2
McLaughlin, T.3
Yazdani, C.4
Stanford, R.H.5
-
12
-
-
0036128508
-
Inhaled corticosteroids plus salmeterol or montelukast: Effects on resource utilization and costs
-
Stempel DA, O'Donnell JC, Meyer JW. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol 2002; 109:433-439.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 433-439
-
-
Stempel, D.A.1
O'Donnell, J.C.2
Meyer, J.W.3
-
13
-
-
0034806733
-
A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy
-
Bukstein DA, Henk HJ, Luskin AT. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy. Clin Ther 2001; 23(9):1589-1600.
-
(2001)
Clin Ther
, vol.23
, Issue.9
, pp. 1589-1600
-
-
Bukstein, D.A.1
Henk, H.J.2
Luskin, A.T.3
-
14
-
-
0034935739
-
Changes in asthma drug therapy-costs for patients receiving chronic montelukast therapy in the UK
-
Price DB, Ben-Joseph RH, Zhang Q. Changes in asthma drug therapy-costs for patients receiving chronic montelukast therapy in the UK. Respir Med 2001; 95(1):83-89.
-
(2001)
Respir Med
, vol.95
, Issue.1
, pp. 83-89
-
-
Price, D.B.1
Ben-Joseph, R.H.2
Zhang, Q.3
-
15
-
-
0043137178
-
A retrospective descriptive medical claims analysis of increased medical risk in asthma management for patients prescribed montelukast compared to fluticasone propionate
-
abstract 1070
-
Edwards LD, Kral KM, Johnson JR, Lincourt WR. A retrospective descriptive medical claims analysis of increased medical risk in asthma management for patients prescribed montelukast compared to fluticasone propionate [abstract 1070]. J Allergy Clin Immunol 2001; 107(2):S329.
-
(2001)
J Allergy Clin Immunol
, vol.107
, Issue.2
-
-
Edwards, L.D.1
Kral, K.M.2
Johnson, J.R.3
Lincourt, W.R.4
-
16
-
-
0036156334
-
Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population
-
Pathak DS, Davis EA, Stanford RH. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population. Pharmacotherapy 2002; 22(2):166-174.
-
(2002)
Pharmacotherapy
, vol.22
, Issue.2
, pp. 166-174
-
-
Pathak, D.S.1
Davis, E.A.2
Stanford, R.H.3
-
17
-
-
0036246647
-
Asthma: Addressing consistency in results from basic science, clinical trials and observational experience
-
Spahn J, Covar R, Stempel DA. Asthma: addressing consistency in results from basic science, clinical trials and observational experience. J Allergy Clin Immunol 2002; 109:S490-S502.
-
(2002)
J Allergy Clin Immunol
, vol.109
-
-
Spahn, J.1
Covar, R.2
Stempel, D.A.3
-
18
-
-
0036256467
-
Approaching value in asthma management: The need to intergrate clinical and economic research with the basic science
-
Stempel DA, Kelly HW. Approaching value in asthma management: the need to intergrate clinical and economic research with the basic science. J Allergy Clin Immunol 2002; 109:S503-S510.
-
(2002)
J Allergy Clin Immunol
, vol.109
-
-
Stempel, D.A.1
Kelly, H.W.2
-
19
-
-
0032411766
-
Treatment of Medicaid patients with asthma: Comparison with treatment guidelines using disease-based drug utilization review methodology
-
Laumann JM, Bjornson DC. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology. Ann Pharmacother 1998; 32(12):1290-1294.
-
(1998)
Ann Pharmacother
, vol.32
, Issue.12
, pp. 1290-1294
-
-
Laumann, J.M.1
Bjornson, D.C.2
-
20
-
-
0035078841
-
A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use
-
Balkrishnan R, Christensen DB. A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use. J Asthma 2001; 38(1):91-98.
-
(2001)
J Asthma
, vol.38
, Issue.1
, pp. 91-98
-
-
Balkrishnan, R.1
Christensen, D.B.2
-
21
-
-
0035186808
-
Effect of prescription benefit changes on medical care utilization in a Medicare HMO population
-
Balkrishnan R, Byerly WG, Camacho FT, Shrestha A, Anderson RT. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Am J Manag Care 2001; 7(11):1093-1100.
-
(2001)
Am J Manag Care
, vol.7
, Issue.11
, pp. 1093-1100
-
-
Balkrishnan, R.1
Byerly, W.G.2
Camacho, F.T.3
Shrestha, A.4
Anderson, R.T.5
-
22
-
-
0034944210
-
Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast
-
Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Respir Med 2001; 95:227-234.
-
(2001)
Respir Med
, vol.95
, pp. 227-234
-
-
Stempel, D.A.1
Mauskopf, J.2
McLaughlin, T.3
Yazdani, C.4
Stanford, R.H.5
-
23
-
-
0037260888
-
Misunderstanding of asthma controller medications: Association with nonadherence
-
Farber HJ, Capra AM, Finkelstein JA, Lozano P, Quesenberry CP, Jensvold NG, Chi FW, Lieu TA. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma 2003; 40(1):17-25.
-
(2003)
J Asthma
, vol.40
, Issue.1
, pp. 17-25
-
-
Farber, H.J.1
Capra, A.M.2
Finkelstein, J.A.3
Lozano, P.4
Quesenberry, C.P.5
Jensvold, N.G.6
Chi, F.W.7
Lieu, T.A.8
-
24
-
-
0033795336
-
Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments
-
Balkrishnan R, Christensen DB. Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments. J Asthma 2000; 37(6):511-517.
-
(2000)
J Asthma
, vol.37
, Issue.6
, pp. 511-517
-
-
Balkrishnan, R.1
Christensen, D.B.2
|